Searched for
COVID ANTIBODY COCKTAIL
Health insurers can't reject Covid claims for antibody cocktail therapy: IrdaiInsurers have been ordered by the regulator to assess claims denied or deductions made in all such cases and take appropriate action to pay...- Covid cases on the rise, experts call for newer drugs, faster approvalsThe Drug Controller General of India had last week approved Merck and Ridgeback’s antiviral molnupiravir for the treatment of mild-to-moder...
- Sourav Ganguly hospitalised after testing positive for Covid-19; stable nowRupali Basu, CEO of Woodlands Hospital, said, “Sourav Ganguly has been admitted at Woodlands Hospital with COVID positive status. He has re...
- China's Brii says its COVID-19 antibody cocktail retains activity against OmicronTest details for the dual-antibody treatment, which last week became the first approved COVID-19 antibody cocktail in China, would not be a...
- Amid spike in cases, EU to shortly approve first COVID antibody drugs - sourcesThe European Medicines Agency (EMA) will this week give the green light to the treatment developed by U.S. biotech firm Regeneron and Swiss...
- AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19"An early intervention with our antibody can give a significant reduction in progression to severe disease, with continued protection for m...
- Cadila Healthcare Q1 results: Net profit rises 29% to Rs 587 crConsolidated total revenue from operations stood at Rs 4,025.4 crore for the quarter under consideration against Rs 3,514.6 crore for the s...
- Antibody cocktail therapy begins at AIIMS, RishikeshAntibody cocktail is a combination of two drugs and its vial costs nearly Rs 60000 in the market.
- Drug cocktail a game changer, say Hyderabad doctorsAbout 100 Covid-19 patients have so far undergone antibody cocktail treatment at various hospitals in the city with successful outcomes.
- Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID-19: SourcesThe only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...
- Doctors call monoclonal antibody cocktail ‘first Covid treatment’The antibody cocktail is a combination of Casirivimab and Imdevimab, which are laboratory made monoclonal antibodies. The cocktail works ju...
- 72-year-old Covid patient given 'antibody cocktail' at Fortis in MohaliThe Mohali-based Fortis Hospital, in a statement, said the patient, who had tested positive for the infection two days ago, is a diabetic w...
- Five patients in Mumbai receive Rs 60,000 drug cocktail that helped Donald TrumpTwo patients in their forties took the monoclonal antibodies in Bandra’s Lilavati Hospital, two others — a 40-year-old man and a 74-year-ol...
- 65 yr old man becomes 1st Covid patient to get antibody cocktail at Apollo in DelhiAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Im...
- GSK gears up to bring antibody cocktail drug to India; Zydus ready for trial“We are exploring all options to quickly make this important medicine available for Indian patients,” GSK India spokesperson told ET. Earli...
- Fortis hospital in Delhi offers monoclonal antibody therapy; awaits takersAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms are offered a cocktail of Casirivimab and Imd...
- India's Zydus Cadila seeks human trial approval for COVID-19 antibody cocktailRegeneron and Roche's antibody cocktail has also received emergency use approval in India, and will be distributed by drugmaker Cipla. The ...
- Cipla to market Roche's Antibody Cocktail in IndiaCipla will distribute the product by leveraging its strong distribution strengths across the country, the companies said in a joint stateme...
- Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatmentRoche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...
- Roche reports promising results from anti-Covid cocktailThe results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab "reduced hospitalisation or death ...
Load More
